CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", "the Company" or "the Group"), a global leader in the supply of life science research ...
Abcam plc (NASDAQ: ABCM) has agreed to acquire BioVision Inc, a wholly-owned Boai NKY Medical Holdings Ltd subsidiary, for $340 million in cash. The Milpitas, California-based BioVision is a ...
(RTTNews) - Abcam Plc (ABCM, ABC.L), a supplier of life science research tools, announced Monday that it has entered into a definitive agreement to acquire BioVision, Inc., a unit of Boai NKY Medical ...
Cambridge-based biotech Abcam is buying Californian diagnostics pioneer BioVision in a $340million cash deal to bring one of its long-term partners in-house. Abcam was launched in 1988 by founder ...
Biovision is launching this years’ registration campaign and its call for applications for innovative projects and companies. This year’s event will take place in Lyon, France, on June 5 and 6, 2014.
Founded in 1999 and located in Milpitas, California, BioVision is a global supplier of life science research tools to support research, diagnostics, and drug discovery. The company is a leading ...
BioVision started supplying Abcam in 2003, and the transaction represents a compelling strategic fit for Abcam. Abcam plans to fund the acquisition from existing cash resources and a partial drawdown ...
2 August 2021, Cambridge, UK – Abcam plc ("Abcam", “the Company” or "the Group") (AIM LSE: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces that it has ...
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", "the Company" or "the Group"), a global leader in the supply of life science research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results